Literature DB >> 21228316

Improved survival in heart transplant recipients in the United States: racial differences in era effect.

Tajinder P Singh1, Christopher Almond, Michael M Givertz, Gary Piercey, Kimberlee Gauvreau.   

Abstract

BACKGROUND: Posttransplant survival in heart transplant recipients has progressively improved during the past 2 decades. It is unknown, however, whether the major racial groups in the United States have benefited equally. METHODS AND
RESULTS: We analyzed all primary heart transplant recipients aged ≥18 years in the United States from 1987 to 2008. We compared posttransplant survival in white, black, and Hispanic recipients in 5 successive eras (1987 to 1992, 1993 to 1996, 1997 to 2000, 2001 to 2004, 2005 to 2008). Early survival was defined as freedom from death or retransplantation during the first 6 months posttransplant. Longer-term, conditional survival was assessed in patients who survived the first 6 months. There were 29 986 (81.6%) white, 4745 (12.9%) black, and 2017 (5.5%) Hispanic patients in the study cohort. Black patients were at increased risk of early death or retransplant (hazard ratio [HR], 1.15; 95% CI, 1.05 to 1.26) in adjusted analysis. Early posttransplant survival improved (HR, 0.83; 95% CI, 0.80 to 0.87 for successive eras) equally in all 3 groups (black-era interaction, P=0.94; Hispanic-era interaction, P=0.40). Longer-term survival improved in white (HR, 0.95; 95% CI, 0.92 to 0.97 for successive eras) but not in black (HR, 1.04; 95% CI, 0.99 to 1.09) or Hispanic (HR, 1.02; 95% CI, 0.95 to 1.09) recipients, resulting in increased disparities in longer-term survival with time.
CONCLUSIONS: Early posttransplant survival has improved equally in white, black, and Hispanic heart transplant recipients. Longer-term survival has improved in white but not in black or Hispanic recipients, resulting in a more marked disparity in outcomes in the current era. These disparities warrant further investigation and targeted interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228316      PMCID: PMC4256951          DOI: 10.1161/CIRCHEARTFAILURE.110.957829

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  30 in total

1.  Unequal treatment: report of the Institute of Medicine on racial and ethnic disparities in healthcare.

Authors:  Alan R Nelson
Journal:  Ann Thorac Surg       Date:  2003-10       Impact factor: 4.330

2.  Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era.

Authors:  J F Valente; S Hariharan; V R Peddi; T J Schroeder; C K Ogle; J W Alexander; M R First
Journal:  Clin Transplant       Date:  1997-06       Impact factor: 2.863

3.  Disproportionate HLA matching may contribute to racial disparity in patient survival following cardiac transplantation.

Authors:  M H Park; D E Tolman; P M Kimball
Journal:  Clin Transplant       Date:  1996-12       Impact factor: 2.863

4.  The impact of race and HLA matching on long-term survival following cardiac transplantation.

Authors:  M H Park; D E Tolman; P M Kimball
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

5.  Strategy of prevention: lessons from cardiovascular disease.

Authors:  G Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-06

6.  Increased costimulatory responses in African-American kidney allograft recipients.

Authors:  A Hutchings; W M Purcell; M R Benfield
Journal:  Transplantation       Date:  2001-03-15       Impact factor: 4.939

7.  The influence of socioeconomic deprivation on outcomes following renal transplantation in the United kingdom.

Authors:  M R Stephens; M Evans; M A Ilham; A Marsden; A Asderakis
Journal:  Am J Transplant       Date:  2010-02-25       Impact factor: 8.086

8.  Seventeen-year experience with 1,083 heart transplants at a single institution.

Authors:  Daniel Marelli; Hillel Laks; Jon A Kobashigawa; Jessica Bresson; Abbas Ardehali; Fardad Esmailian; Mark D Plunkett; Bernard Kubak
Journal:  Ann Thorac Surg       Date:  2002-11       Impact factor: 4.330

9.  Use of rapamycin slows progression of cardiac transplantation vasculopathy.

Authors:  Donna Mancini; Sean Pinney; Daniel Burkhoff; John LaManca; Silviu Itescu; Elizabeth Burke; Niloo Edwards; Mehmet Oz; Andrew R Marks
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

10.  Effect of pravastatin on outcomes after cardiac transplantation.

Authors:  J A Kobashigawa; S Katznelson; H Laks; J A Johnson; L Yeatman; X M Wang; D Chia; P I Terasaki; A Sabad; G A Cogert
Journal:  N Engl J Med       Date:  1995-09-07       Impact factor: 91.245

View more
  11 in total

Review 1.  Pharmacogenomics: personalizing pediatric heart transplantation.

Authors:  Sara L Van Driest; Steven A Webber
Journal:  Circulation       Date:  2015-02-03       Impact factor: 29.690

2.  Mortality, rehospitalization, and post-transplant complications in gender-mismatched heart transplant recipients.

Authors:  Anne Jalowiec; Kathleen L Grady; Connie White-Williams
Journal:  Heart Lung       Date:  2017-05-10       Impact factor: 2.210

Review 3.  Racial and ethnic disparities in outcomes after heart transplantation: A systematic review of contributing factors and future directions to close the outcomes gap.

Authors:  Alanna A Morris; Evan P Kransdorf; Bernice L Coleman; Monica Colvin
Journal:  J Heart Lung Transplant       Date:  2016-02-12       Impact factor: 10.247

4.  Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).

Authors:  Kevin J Clerkin; Arthur Reshad Garan; Brian Wayda; Raymond C Givens; Melana Yuzefpolskaya; Shunichi Nakagawa; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara
Journal:  Circ Heart Fail       Date:  2016-10       Impact factor: 8.790

Review 5.  Racial disparities in surgical care and outcomes in the United States: a comprehensive review of patient, provider, and systemic factors.

Authors:  Adil H Haider; Valerie K Scott; Karim A Rehman; Catherine Velopulos; Jessica M Bentley; Edward E Cornwell; Waddah Al-Refaie
Journal:  J Am Coll Surg       Date:  2013-01-11       Impact factor: 6.113

6.  Better Understanding the Disparity Associated With Black Race in Heart Transplant Outcomes: A National Registry Analysis.

Authors:  Hasina Maredia; Mary Grace Bowring; Allan B Massie; Sunjae Bae; Amber Kernodle; Shakirat Oyetunji; Christian Merlo; Robert S D Higgins; Dorry L Segev; Errol L Bush
Journal:  Circ Heart Fail       Date:  2021-02-02       Impact factor: 8.790

7.  The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage.

Authors:  Jay N Patel; Dmitry Abramov; Marat Fudim; Ike S Okwuosa; David G Rabkin; Joshua S Chung
Journal:  Clin Transplant       Date:  2022-03-12       Impact factor: 3.456

8.  Gene expression profiling to study racial differences after heart transplantation.

Authors:  Kiran K Khush; Michael X Pham; Jeffrey J Teuteberg; Abdallah G Kfoury; Mario C Deng; Andrew Kao; Allen S Anderson; William G Cotts; Gregory A Ewald; David A Baran; David Hiller; James Yee; Hannah A Valantine
Journal:  J Heart Lung Transplant       Date:  2015-02-07       Impact factor: 10.247

9.  Ethnic disparity in Israel impacts long-term results after heart transplantation.

Authors:  Yael Peled; Ron Loewenthal; Yigal Kassif; Eugenia Raichlin; Arwa Younis; Anan Younis; Eyal Nachum; Dov Freimark; Jacob Lavee
Journal:  Isr J Health Policy Res       Date:  2019-01-14

10.  Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation.

Authors:  Fouad Chouairi; Michael Fuery; Katherine A Clark; Clancy W Mullan; James Stewart; Cesar Caraballo; John-Ross D Clarke; Sounok Sen; Avirup Guha; Nasrien E Ibrahim; Robert T Cole; Louisa Holaday; Muhammed Anwer; Arnar Geirsson; Joseph G Rogers; Eric J Velazquez; Nihar R Desai; Tariq Ahmad; P Elliott Miller
Journal:  J Am Heart Assoc       Date:  2021-08-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.